Cure My Disease

Don't miss your cure!

 Log in / Sign up

A 12-minute video could save new mothers' lives – can it teach them to spot danger?

NCT ID NCT06310720

Knowledge-focused Sponsor: Weill Medical College of Cornell University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 21, 2026 · Last updated Aug 21, 2026

Summary

This trial tests whether a 12-minute educational video, shown at hospital discharge, improves new mothers' knowledge of warning signs for severe postpartum complications like hemorrhage, infection, and high blood pressure. Participants – who are Black, Latinx, multiracial, Medicaid, or uninsured – are randomly assigned to receive the video plus standard written instructions, or standard care alone. They complete questionnaires to measure knowledge before and after the education. The goal is to see if video education can empower mothers to recognize danger signs in the first week after delivery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A 12-minute educational video covering postpartum warning signs for hemorrhage, infection, hypertension, and depression.
What this could lead to
If effective, this approach could become a standard tool to help new mothers recognize dangerous symptoms early, potentially reducing severe postpartum complications.
What could go wrong
The trial is small (50 participants) and measures knowledge improvement, not actual health outcomes. Video education may not translate into real-world recognition or action, and results may not apply to broader populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

50 people

The number who actually took part.

Started

May 2024

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age \>18 years * Speaks English or Spanish * Informed and written consent * Delivered at WCM * Received prenatal, and will receive postpartum, care through a WCM-affiliated obstetric and/or midwifery practice * Self-identified as Black, Latinx, other and/or Medicaid or Uninsured Exclusion Criteria: * Patients who do not plan to receive postpartum care within the WCM system * Patients who experience an intrauterine fetal demise * Patients who speak a primary language other than English or Spanish

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Patient education are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Patient Participation postpartum depression Postpartum Hemorrhage preeclampsia puerperal infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Patient education Patient empowerment Postpartum care Postpartum depression Postpartum hemorrhage Postpartum preeclampsia Postpartum sepsis

Contacts and locations

Locations

  • Alexandra Cohen Hospital for Women and Newborns

    New York, New York, 10065, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.